CHRISTINA BASHAM: Open Payments
NPI 1992108823 · LONG BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$663 in 37 payments from 12 companies in 2025. Trend: 2023 $794 · 2024 $781 · 2025 $663
Food & beverage: $663
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 17 | $163 |
| ABBVIE INC. | 4 | $96 |
| REVANCE THERAPEUTICS, INC. | 4 | $79 |
| E.R. Squibb & Sons, L.L.C. | 2 | $66 |
| LEO Pharma Inc. | 2 | $50 |
| PFIZER INC. | 2 | $39 |
| UCB, Inc. | 1 | $38 |
| Regeneron Healthcare Solutions, Inc. | 1 | $38 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $29 |
| Arcutis Biotherapeutics, Inc. | 1 | $25 |
Products named: OPZELURA, DAXXIFY, Sotyktu, ADBRY, CIBINQO, Bimzelx, DUPIXENT, ILUMYA.
Industry payments across CA — which companies pay providers there.
